Blood pressure medications safe for COVID-19 patients: Study
Video Credit: ANI - Duration: 01:10s - Published
Blood pressure medications safe for COVID-19 patients: Study
An international team of researchers have found that medications to treat high blood pressure do not affect outcomes among patients hospitalized with COVID-19.
The study, led by researchers from Perelman School of Medicine at the University of Pennsylvania, published today in The Lancet Respiratory Medicine, is the first randomized controlled trial to show there is no risk for patients continuing these medications while hospitalized for COVID-19.
More than 49 million U.S. adults take medication to treat hypertension, and among those, about 83 percent (41 million) take an ACEI or ARB, according to the Centers for Disease Control and Prevention.
Early during the pandemic, a concern arose regarding the use of ACEIs or ARBs in the setting of COVID-19, since some studies had suggested that these medications could upregulate cellular receptors for the SARS-CoV-2 virus potentially aiding viral replication.
However, it was also considered that some effects of these medications could be protective against the virus.
ACEIs and ARBs are among the most commonly prescribed medications in the world, and a potential link between those medications and COVID-19 outcomes has large global health implications, the authors say.
Several observational studies suggested no association between outpatient ACEI or ARB use and risk of COVID-19 hospitalization, but high-quality randomized trial evidence was lacking, until now.
Currently, trials are underway to determine if the use of these medications is effective for the treatment of COVID-19.
US Surgeon General , Declares Gun Violence in America , a ‘Public Health Crisis’.
U.S. Surgeon General Dr. Vivek Murthy
made the declaration in a new advisory released on June 25, CNN reports.
It is the first time that a surgeon general
has focused on gun violence's "profound consequences" in a national publication. .
Over the last decade or two,
this problem has been worsening and we
have now reached the point where gun violence is the leading cause of death among kids and teens – the leading cause of death. , Dr. Vivek Murthy, to CNN's John Berman.
That is something that we should
never take as the new normal.
There’s nothing normal about that, Dr. Vivek Murthy, to CNN's John Berman.
According to Murthy, the advisory is intended to take the polarizing issue of firearms "out of the realm of politics and put it into the realm of public health, which is where it belongs.".
According to Murthy, the advisory is intended to take the polarizing issue of firearms "out of the realm of politics and put it into the realm of public health, which is where it belongs.".
The advisory highlights measures that Murthy believes can have an impact on gun violence.
just as steps to address vehicle crashes and tobacco-related illnesses have in the past. .
just as steps to address vehicle crashes and tobacco-related illnesses have in the past. .
Historically, we have seen how the
release of Surgeon General reports on
public health issues such as the dangers
of smoking ignited a wave of policy,
legal, and public health initiatives.., Dr. Joseph V. Sakran, Brady board chair
and chief medical officer, via CNN.
... that saved countless American
lives and in this case led to
deprogramming our nation from
the tobacco industry’s lies. , Dr. Joseph V. Sakran, Brady board chair
and chief medical officer, via CNN.
We hope this report will have
the same resounding impact on
the gun violence epidemic, Dr. Joseph V. Sakran, Brady board chair
and chief medical officer, via CNN.
In 2022, over 48,000 people in America died from gun-related injuries, according to CDC data.
In the new advisory, Dr. Murthy said, "It is up to
us to take on this generational challenge with
the urgency and clarity the moment demands.".
The safety and well-being
of our children and future generations are at stake, Dr. Vivek Murthy, via advisory
Credit: Wibbitz Top Stories Duration: 01:31Published
FDA Reverses Ban , on Juul E-Cigarettes.
On June 6, the Food and Drug Administration
announced that it has reversed its ban on Juul
e-cigarettes while the agency reviews new information.
On June 6, the Food and Drug Administration
announced that it has reversed its ban on Juul
e-cigarettes while the agency reviews new information.
NBC reports that the FDA first ordered Juul to take its
product off the market in 2022, however the e-cigarettes
have remained on shelves pending the company's appeal.
NBC reports that the FDA first ordered Juul to take its
product off the market in 2022, however the e-cigarettes
have remained on shelves pending the company's appeal.
In that time, Juul has maintained
its position as the second-most
popular e-cigarette in the U.S.
The FDA noted that reversing the ban
temporarily was not an indication that the
company's product would be ultimately cleared. .
The FDA noted that reversing the ban
temporarily was not an indication that the
company's product would be ultimately cleared. .
Sales of alternative nicotine
products, like e-cigarettes, have
continued to grow in the past decade. .
In 2023, the Centers for Disease Control and
Prevention reported that e-cigarette use had
grown by almost 50% between 2020 and 2022. .
In 2023, the Centers for Disease Control and
Prevention reported that e-cigarette use had
grown by almost 50% between 2020 and 2022. .
Juul released a statement
following the FDA reversal, .
... saying the company looks forward to "re-engaging
with the agency on a science- and evidence-based
process to pursue a marketing authorization.".
We remain confident in the quality
and substance of our applications
and believe that a full review of
the science and evidence will
demonstrate that our products
meet the statutory standard
of being appropriate for
the protection of public health, Juul statement, via NBC.
We remain confident in the quality
and substance of our applications
and believe that a full review of
the science and evidence will
demonstrate that our products
meet the statutory standard
of being appropriate for
the protection of public health, Juul statement, via NBC.
'The Wall Street Journal' reports that Juul has argued
that the 2022 ban significantly disrupted the company's
finances, resulting in an investor bailout.
Currently, the FDA has only granted approval for 23
e-cigarette products, manufactured by only three
companies, to be marketed and sold to consumers
Credit: Wibbitz Top Stories Duration: 01:31Published
A recent study suggested that people who have a higher omega-3 index have a lower probability of dying due to COVID-19.Researchers with the Fatty Acid Research Institute (FARI) and collaborators at..
Another detailed study by the American Association for the Advancement of Science asserts that the SARS-CoV-2 virus not only targets to enter the human cells but begin to replicate and spread as well...
As Floridians flock to COVID vaccine sites in the rush to get vaccinated, many who are dealing with high blood pressure have questions about their medications and how these might impact their recovery..
![US Surgeon General Declares Gun Violence in America a ‘Public Health Crisis’ [Video]](https://video.newsserve.net/300/v/20240625/1379588994-US-Surgeon-General-Declares-Gun-Violence-in-America.jpg)
![FDA Reverses Ban on Juul E-Cigarettes [Video]](https://video.newsserve.net/300/v/20240606/1377709014-FDA-Reverses-Ban-on-Juul-Cigarettes.jpg)
![High omega-3 index people less likely to die from COVID-19: Study [Video]](https://video.newsserve.net/300/v/20210127/2101270106-High-omega-index-people-less-likely-to.jpg)
![New study explains how SARS-CoV-2 may seize human cells [Video]](https://video.newsserve.net/300/v/20210123/2101230358-New-study-explains-how-SARS-CoV-may.jpg)
![UM Conducts Study On Impact Of High-Blood Pressure Medications On COVID Patients [Video]](https://video.newsserve.net/300/v/20210122/2101222337-UM-Conducts-Study-On-Impact-Of-High-Blood.jpg)
